Compare CLDX & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | ATRO |
|---|---|---|
| Founded | N/A | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | 1995 | 1995 |
| Metric | CLDX | ATRO |
|---|---|---|
| Price | $38.43 | $67.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $46.60 | ★ $86.00 |
| AVG Volume (30 Days) | ★ 678.9K | 497.8K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 276.09 |
| EPS | N/A | ★ 1.31 |
| Revenue | $12,743,000.00 | ★ $862,128,000.00 |
| Revenue This Year | $111.39 | $14.92 |
| Revenue Next Year | $235.85 | $8.81 |
| P/E Ratio | ★ N/A | $51.11 |
| Revenue Growth | ★ 87.78 | 8.39 |
| 52 Week Low | $22.10 | $39.14 |
| 52 Week High | $45.14 | $99.89 |
| Indicator | CLDX | ATRO |
|---|---|---|
| Relative Strength Index (RSI) | 45.97 | 34.89 |
| Support Level | $28.51 | $63.78 |
| Resistance Level | $40.30 | $79.86 |
| Average True Range (ATR) | 1.37 | 2.84 |
| MACD | -0.29 | -0.90 |
| Stochastic Oscillator | 31.63 | 5.71 |
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Astronics Corporation is a provider of technologies to the aerospace, defense, and electronics industries, offering high-performance electrical power generation and distribution systems, motion systems, lighting and safety systems, avionics products, systems certification, aircraft structures, and automated test systems. The company operates through two reportable segments, Aerospace and Test Systems. The Aerospace segment designs and manufactures products for the aerospace and defense industry and generates the majority of revenue, while the Test Systems segment designs, develops, manufactures, and maintains automated test systems for the aerospace and defense, communications, and mass transit industries. The company derives the majority of its revenue from the United States.